Company · CIK 1210336

# Grant Life Sciences, Inc.

| CIK | [1210336](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001210336) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2835 — In Vitro & In Vivo Diagnostic Substances |
| Incorporated in | NV |
| Business address | UT |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2005-03-31 |

## Offerings

 0 registrations

No offering chain starts here after 2002-11-04: the company's filings belong to registrations filed earlier, or to drafts and notices only.

## Filings

 2

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2008-01-29 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1210336/999999999508000329/9999999995-08-000329-index.htm) Declared effective | 333-148366 | 9999999995-08-000329 |
| 2006-12-28 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1210336/999999999506002920/9999999995-06-002920-index.htm) Declared effective | 333-137774 | 9999999995-06-002920 |

[All filings of this company](https://equitycapital.markets/filings?cik=1210336) · [CSV](https://equitycapital.markets/filings.csv?cik=1210336)

---
Source page: https://equitycapital.markets/company/1210336 · Data: U.S. SEC EDGAR · CC BY 4.0